• OUR STATEMENT ON COVID-19
    Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc.
    • About Us
    • Pipeline
    • Therapeutic focus
    • Contact us
    • Investors
    Open

    Financial Results

    Investors

    Investors

    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Videos
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
      • Board Diversity Matrix

    • Financial Info

    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow

    2023

    Q3 2023

    Quarter Ended Mar 31, 2023
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q2 2023

    Quarter Ended Dec 31, 2022
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q1 2023

    Quarter Ended Sep 30, 2022
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    2022

    FY 2022

    Fiscal Year Ended Jun 30, 2022
    Earnings Release
    PDF HTML
    10-K Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q3 2022

    Quarter Ended Mar 31, 2022
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q2 2022

    Quarter Ended Dec 31, 2021
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q1 2022

    Quarter Ended Sep 30, 2021
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    2021

    FY 2021

    Fiscal Year Ended Jun 30, 2021
    Earnings Release
    PDF HTML
    10-K Filing
    PDF HTML
    XBRL
    ZIP XLS HTML

    Q3 2021

    Quarter Ended Mar 31, 2021
    Earnings Release
    PDF HTML
    10-Q Filing
    PDF HTML
    XBRL
    ZIP XLS HTML
    • Email Alerts
    • Contacts
    • RSS News Feed

    Contact

    Anebulo Pharmaceuticals
    1415 Ranch Road 620 South
    Austin, TX 78734
    Phone: 512-598-0931
    Email: info@anebulo.com

    About

    Our Mission
    Management Team
    Board of Directors

    Pipeline

    • ANEB-001
    Anebulo Pharmaceuticals, Inc.
    Facebook Twitter Instagram Reddit
    Back to top

    ©2023 Anebulo Pharmaceuticals. All Rights Reserved.

    Privacy Policy | Terms of Use